Abstract 1036: Detection of circulating tumor DNA by whole genome sequencing enables prediction of recurrence in stage III colorectal cancer patients with great inter-lab reproducibility

Amanda Frydendahl(Aarhus University), Claus L. Andersen(Aarhus University), Lene Hjerrild Iversen(Aarhus University Hospital), Kandasamy Ravi(ID Genomics (United States)), Iman Tavassoly(ID Genomics (United States)), Jurica Levatić(ID Genomics (United States)), Ryan Ptashkin(Memorial Sloan Kettering Cancer Center), Danielle Afterman(IBM Research - Haifa), Sunil Deochand(ID Genomics (United States)), Paz Polak(Broad Institute), Eric J. White(ID Genomics (United States)), Uffe S. Løve(Regionshospitalet Viborg), Dunja Glavaš(ID Genomics (United States)), Tomer Lauterman(IBM Research - Haifa), Michael Yahalom(IBM Research - Haifa), Santiago González(Vir Biotechnology (Switzerland)), Jesper B. Bramsen(Goethe University Frankfurt), Dillon Maloney(ID Genomics (United States)), Kåre Andersson Gotschalck(Regional Hospital Randers), Thomas Reinert(Aarhus University Hospital), Asaf Zviran(Q Therapeutics (United States)), Maja Kuzman(ID Genomics (United States)), Boris Oklander(IBM Research - Haifa), Ury Alon(IBM Research - Haifa), Anders Husted Madsen(Regionshospitalet Herning), Ole Thorlacius‐Ussing(Aalborg University), Jesper Nors(Aarhus University), James Samdbeck, Mads Heilskov(Aarhus University Hospital), Zohar Donenhirsh(IBM Research - Haifa), Ester Ellegaard Sørensen(Aarhus University Hospital), Per Vadgaard Andersen(Odense University Hospital)

Cancer Research

April 4, 2023

Cited by 1

Related Papers

|Nature|2019|1.5k

|Science Translational Medicine|2017|1.1k

|JAMA Oncology|2019|992

|Nature Genetics|2020|739

|Nature Genetics|2018|701